Company
United StatesPublic company, NYSE: PFEPfizer Inc (NYSE: PFE), Chesterfield, MO – FDA Inspections
Inspection records and compliance data for Pfizer Inc in Chesterfield, Missouri. 4 FDA inspections on record, last inspected August 20, 2019. Publicly traded as NYSE: PFE.
Company Profile
This profile covers Pfizer Inc based in Chesterfield, Missouri, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected February 29, 2012. Last inspected August 20, 2019.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 20, 2019 | NAI | Human Drugs · Drug Quality Assurance | 1101585 |
| February 16, 2016 | VAI | Human Drugs · Drug Quality Assurance | 969406 |
| May 21, 2014 | NAI | Human Drugs · Drug Quality Assurance | 879922 |
| February 29, 2012 | NAI | Human Drugs · Drug Quality Assurance | 769902 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Pfizer Inc
Stock ticker
PFE
Exchange
NYSE
Share price
$29.91
Market cap
$170.5B
Price as of
November 6, 2026
FEI Number
1940118
Address
875 Chesterfield Pkwy W, Chesterfield, Missouri 63017, United States
Country
United States
ID: 144866e0-8b03-436f-a174-9ae92a9c9fc5